Description

This research segment presents the key highlights from the 2010 American College of Rheumatology (ACR) for the treatment of systemic lupus erythematosus (SLE). The purpose of this study is to highlight the current and future treatments for SLE, identify and analyze key data presented at ACR 2010, and discuss recent developments in the SLE market. This study includes content from interviews conducted with key opinion leaders (KOLs) and company executives.